Company intelligence / Profile preview

Innitius

Bilbao, Basque Country, Spaininnitius.com ↗

Ownership: Private
Development stage: Clinical

Overview

The Fine Birth device has demonstrated strong clinical validation in initial studies and laboratory settings. It provides real-time risk assessment of spontaneous preterm delivery within seven days after a threatened event. Broader clinical adoption and regulatory approvals are pending before full market entry.

Therapeutic areas: Women's Health
Modalities: DeviceArtificial Intelligence (AI)-enabled diagnostics
Industry: Medical Imaging

Partnerships

University of GranadaAndalusian Health Service

Beyond the preview

Go deeper on Innitius.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innitius.

Explore the full profile